Eliav Barr
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Eliav Barr is currently an Independent Director at Veracyte, Inc. since 2022.
Dr. Barr is also the Chief Medical Officer at Merck Research Laboratories Massachusetts LLC since 2022.
Dr. Barr completed undergraduate studies at The Pennsylvania State University and earned a doctorate from Sidney Kimmel Medical College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERACYTE, INC. 0,07 % | 11/06/2026 | 56 461 ( 0,07 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VERACYTE, INC. | Directeur/Membre du Conseil | 09/08/2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Directeur Technique/Scientifique/R&D | 01/04/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national